Danaher unveils AI lab designed for up to 8x faster discovery; stock pre-market at EUR 193.93
Published on 10/09/2026 at 07:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Danaher announced an AI-powered autonomous lab on October 7, 2026.
- The lab is designed for up to 8x faster affinity-reagent discovery.
- Danaher stock was at EUR 193.93 in pre-market trading at 7:51 a.m. CEST.
Danaher Corporation announced plans on October 7, 2026, for its first AI-powered autonomous lab, designed to accelerate the development of custom antibodies and other molecular tools. Danaher stock was at EUR 193.93 at Lang & Schwarz at 7:51 a.m. CEST on October 9, 2026.
Pre-market trading
The lab is designed to deliver up to 8x faster discovery of affinity reagents and up to a tenfold increase in annual reagent generation as it scales. The pre-market price was EUR 193.93 at Lang & Schwarz at 7:51 a.m. CEST on October 9, 2026. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Danaher stock.
What matters today
Danaher’s next quarterly earnings conference call is scheduled for October 21, 2026, at 8:00 a.m. ET. A move to the round-number level of EUR 200.00 would represent a 3.13 percent increase from EUR 193.93. The autonomous lab is designed to increase annual reagent generation by up to tenfold as it scales.
Autonomous laboratory plans
The company said the lab will combine artificial intelligence, robotics and technologies from several Danaher operating companies in one connected workflow. It will be based at Abcam, a Danaher company, and will use a design-make-test-learn cycle for new affinity reagents. Danaher Corporation said the initiative is an early step in a broader program involving smart instruments, connected workflows and autonomous laboratories.
Market context: Market report S&P 500.
